Apple Watch ®

June 1, 2022

Caption Health

June 1, 2022

Netherlands

Published by Daniel at June 1, 2022

The Netherlands has an abundance of AI-driven companies making rapid and significant contributions to various healthcare fields...

New Amsterdam Pharma

New Amsterdam Pharma (NAP) is a clinical-stage company focused on developing transformative medicine for cardio-metabolic conditions. Their goal is to enhance patient management when conventional treatments are not tolerated or have been unsuccessful. The company is investigating and developing phase 3 of its ApoB and LDL-c lowering small molecule drug that potently induces cholesterol efflux to reduce the established atheroma burden.(1)

New Amsterdam Pharma

The company is investigating and developing phase 3 of its ApoB and LDL-c lowering small molecule drug that potently induces cholesterol efflux to reduce the established atheroma burden.(1)

NorthSea Therapeutics:

NorthSea Therapeutics is a health-stage biotech organization developing top-quality, structurally engineered oral lipid therapeutics to target metabolic, inflammatory, and fibrotic diseases. The Structurally Engineered Fatty Acid (SEFA) technology devises novel distinctive curative approaches and potential drugs.

With a broad array of inter-and independent biological effects, some products improve dyslipidemia, insulin resistance, hepatic inflammation, and fibrosis in diverse models.SEFA-6179 is being developed as an oral therapy for parenteral nutrition-associated liver disease (PNALD), an orphan liver disease caused by long-term use of parenteral nutrition.Piglet PK research indicated a sustainable utilization of SEFA-6179 via the oral way. It commenced the formal GLP toxicology program to permit an Investigational New Drug (IND) filling in the first half of 2021.(2)

NorthSea Therapeutics:

NorthSea Therapeutics is a health-stage biotech organization developing top-quality, structurally engineered oral lipid therapeutics to target metabolic, inflammatory, and fibrotic diseases.

The Structurally Engineered Fatty Acid (SEFA) technology devises novel distinctive curative approaches and potential drugs.With a broad array of inter-and independent biological effects, some products improve dyslipidemia, insulin resistance, hepatic inflammation, and fibrosis in diverse models.

SEFA-6179 is being developed as an oral therapy for parenteral nutrition-associated liver disease (PNALD), an orphan liver disease caused by long-term use of parenteral nutrition.Piglet PK research indicated a sustainable utilization of SEFA-6179 via the oral way. It commenced the formal GLP toxicology program to permit an Investigational New Drug (IND) filling in the first half of 2021.(2)

Xilloc:

For example, the new Xilloc Temporomandibular Joint Groningen prostheses represent the top technical standard. It achieves a more mechanically stable fixation, is designed to follow the surface of the mandible and skull and allows more natural rotation and translation.(3)

Xilloc:

Xilloc Medical aims to provide patient-specific implants to replace pieces of the human skeleton. These implants can bridge the gap between the doctor and individually engineered, distinctive products to improve patients’ quality of life.For example, the new Xilloc Temporomandibular Joint Groningen prostheses represent the top technical standard.

It achieves a more mechanically stable fixation, is designed to follow the surface of the mandible and skull and allows more natural rotation and translation.(3)

Castor:

Castor allows researchers to easily capture and integrate high-quality data on one compliant platform from any source. Thousands of medical devices, biotech, and academic researchers worldwide are now using Castor EDC (Electronic Data Capture), eCRF, ePRO, and eTMF to accelerate their studies. The organization’s goal is to use the new funding to strengthen its base for patient-centric, remote trials and allow persons to enhance value from existing and newly generated data throughout the clinical trial affair.

In February 2020, Castor enhanced the worldwide combat against Coronavirus by offering its EDC system accessible to all COVID-19 research projects. This effort allowed prompt distribution of data regarding Coronavirus vaccines and healing. Castor is now supporting over 100 studies.(4)

Castor:

The organization’s goal is to use the new funding to strengthen its base for patient-centric, remote trials and allow persons to enhance value from existing and newly generated data throughout the clinical trial affair.In February 2020, Castor enhanced the worldwide combat against Coronavirus by offering its EDC system accessible to all COVID-19 research projects. This effort allowed prompt distribution of data regarding Coronavirus vaccines and healing. Castor is now supporting over 100 studies.(4)

NovioSense:

NovioSense is a company that aims to develop a clinical prototype device to prove the principle of glucose measurement in tears and create strategic partnerships to bring the technology to the market. It is entering clinical trials of its sensor systems for tolerance and expects to address efficacy. The platform consists of a flexible spring-like sensor unit connected to ASIC technology co-developed by the Fraunhofer Institute for Microelectronic Circuits and Systems and NovioSense.

The sensor is placed in the lower eyelid and can measure minute changes in glucose level in tears that are representative of blood glucose levels. The device is RFID powered, and data is collected wirelessly. The device is compatible with any NFC-enabled mobile phone and can measure continuously and on-demand.(5)

NovioSense:

NovioSense is a company that aims to develop a clinical prototype device to prove the principle of glucose measurement in tears and create strategic partnerships to bring the technology to the market. It is entering clinical trials of its sensor systems for tolerance and expects to address efficacy.The platform consists of a flexible spring-like sensor unit connected to ASIC technology co-developed by the Fraunhofer Institute for Microelectronic Circuits and Systems and NovioSense.

ArtPred:

ARTPred is an emerging technology intended to demonstrate the odds of an embryo’s failure to insert into the uterus during the in-vitro fertilization method. It is a revolutionary approach to tackle one of the biggest problems encountered during in-vitro fertilization. The platform is based on biomarker profiles of the urogenital microbiome.(6)

ArtPred:

ARTPred is an emerging technology intended to demonstrate the odds of an embryo’s failure to insert into the uterus during the in-vitro fertilization method.

It is a revolutionary approach to tackle one of the biggest problems encountered during in-vitro fertilization. The platform is based on biomarker profiles of the urogenital microbiome.(6)

BeSure:

BeSure is a data-driven platform used for daily monitoring of geriatric patients, stroke prevention, cardiovascular risk mitigation, and medical decision support. They focus on stroke being the primary cause of complex long-term disability and the second cause of death. They use wearable, IoT, and medical devices to make real-time analyses of leading health indicators to predict the onset of emergent situations.(7)

BeSure:

They use wearable, IoT, and medical devices to make real-time analyses of leading health indicators to predict the onset of emergent situations.(7)

Landcent:

Landcent is the only company that has developed products across all three WHO-recommended categories to prevent malaria effectively.

In response to the rise of insecticide resistance, Landcent has begun to pursue sustainable compounds that can be used safely at scale. The health innovation company is also working on its future product pipeline, harnessing naturally occurring compounds to develop preventative technologies for infectious diseases related to poverty, such as tuberculosis and HIV/AIDS.(8)

Landcent:

Landcent is the only company that has developed products across all three WHO-recommended categories to prevent malaria effectively.In response to the rise of insecticide resistance, Landcent has begun to pursue sustainable compounds that can be used safely at scale.

The health innovation company is also working on its future product pipeline, harnessing naturally occurring compounds to develop preventative technologies for infectious diseases related to poverty, such as tuberculosis and HIV/AIDS.(8)